Antifungal therapy shows potential for IBD patients with Candida overgrowth

A commonly utilized systemic antifungal medicine whitethorn assistance trim symptoms successful a subset of patients with inflammatory bowel illness (IBD) by restoring a healthier gut microbiome, according to a preliminary survey by Weill Cornell Medicine investigators. The study, published successful Nature Medicine, provides what is thought to beryllium the archetypal grounds that targeting intestinal fungal dysbiosis tin reshape bacterial and fungal microbiome dynamics successful patients with IBD and establishes a model for mycobiome-guided precision therapies.